Kirloskar Oil Engines

Similar documents
Amber Enterprises India Ltd

Goodyear India BUY. Company Update. CMP Target Price `515 `631. Company Update Tyres. 3-year Daily Price Chart. Key Financials

ITC ACCUMULATE. Performance Highlights CMP. `257 Target Price `284. 3QFY2017 Result Update FMCG. Investment Period 12 Months

Coal India ACCUMULATE. Performance Highlights CMP. `338 Target Price `380. Outlook and valuation. 2QFY2016 Result Update Mining

Garware Wall Ropes ACCUMULATE. Performance Highlights CMP. `550 Target Price `618. 2QFY2017 Result Update Textile. Investment Period 12 months

Hindustan Media Ventures

Parag Milk Foods BUY. Performance Update CMP. `256 Target Price `330. 2QFY2019 Result Update Dairy Products. Investment Period 12 Months

ACC BUY. Performance Highlights. CMP `1,397 Target Price `1,630. 3QCY2015 Result Update Cement

Mahindra & Mahindra Ltd.

Maruti Suzuki India BUY. Performance Update. CMP `9,315 Target Price `10,820. 1QFY2019 Result Update Automobile. Historical share price chart

GMM Pfaudler Limited BUY. Performance Update CMP. `945 Target Price ` QFY2019 Result Update Industrial Machinery. Investment Period 12 Months

Blue Star Ltd BUY. Performance Update. CMP Target Price `703 `867. 1QFY2019 Result Update Cons. Durable. 3-year price chart.

Rallis India NEUTRAL. Performance Highlights CMP. `237 Target Price - 1QFY2018 Result Update Agrichemical. Investment Period - 3-year price chart

Tata Steel NEUTRAL. Performance Highlights CMP. `226 Target Price - 2QFY2016 Result Update Steel. Investment Period - 3-year price chart

Rallis India NEUTRAL. Performance Highlights CMP. `215 Target Price - 3QFY2017 Result Update Agrichemical. Investment Period - 3-year price chart

Rallis India NEUTRAL. Performance Highlights CMP. `242 Target Price - 4QFY2017 Result Update Agrichemical. Investment Period - 3-year price chart

Mahindra & Mahindra Ltd.

TV Today Network BUY. Performance Update CMP. `323 Target Price `498. 3QFY2019 Result Update Media. Investment Period 12 Months

Procter & Gamble Hygiene & Health Care

Ambuja Cements ACCUMULATE. Performance Highlights. CMP Target Price `207 `233. 3QCY2015 Result Update Cement. Quarterly results (Standalone)

Inox Wind BUY. Performance Highlights. CMP Target Price `242 `286. 4QFY2016 Result Update Capital Goods. 3 year price chart

Amara Raja Batteries BUY. Performance Highlights. CMP `1,010 Target Price `1,167. 2QFY2017 Result Update Auto Ancillary. 3-year price chart

Parag Milk Foods BUY. Performance Update CMP. `324 Target Price `410. 1QFY2019 Result Update Dairy Products. Investment Period 12 Months

Quick take. Ruchira Papers Ltd. BUY. Creating value through paper. Target Price. Investment Period 12 Months. 3 year daily price chart.

Maruti Suzuki India BUY. Performance Update. CMP `6,705 Target Price `8,552. 2QFY2019 Result Update Automobile. Historical share price chart

Rallis India SELL. Performance Highlights. `231 Target Price 189 CMP. 2QFY2018 Result Update Agrichemical. Investment Period 12 months

Inox Wind BUY. Performance Highlights. CMP Target Price `390 `505. 2QFY2016 Result Update Capital Goods. 3 year price chart

Music Broadcast BUY. Performance Update. CMP Target Price `329 `475. 2QFY2019 Result Update Media. Historical share price chart.

Bata India BUY. Performance Update. CMP Target Price `842. 1QFY2019 Result Update Footwear. Historical share price chart.

Asian Granito BUY. Performance Highlights CMP. `270 Target Price `351. Outlook and valuation. 3QFY2017 Result Update Ceramics

Bata India BUY. Performance Update. CMP `1,008 Target Price `1,243. 2QFY2019 Result Update Footwear. Historical share price chart.

Music Broadcast BUY. Performance Update. CMP Target Price `293 `475. 3QFY2019 Result Update Media. Stock Info Sector Market Cap (Rs cr) Media

Goodyear India ACCUMULATE. Performance Highlights. CMP Target Price `326 `374. 1QCY2012 Result Update Tyres. Key financials

GAIL India NEUTRAL. Performance Highlights CMP. `363 Target Price - 2QFY2013 Result Update Oil & Gas. Investment Period -

KEI Industries BUY. Performance Update. Target Price. 3QFY2018 Result Update Cable. Historical share price chart. Key Financials

MRF BUY. Performance Highlights. CMP `9,407 Target Price `11,343. Company Update Automobile. Key financials

Hero MotoCorp ACCUMULATE. Performance Highlights. CMP `3,226 Target Price `3,466. 3QFY2017 Result Update Automobile. 3-year price chart

Graphite India BUY. Performance Highlights CMP. `93 Target Price `124. 4QFY2012 Result Update Capital Goods. Investment Period 12 Months

Greenply Industries BUY. The plywood maker for growing India. Target Price. Initiating Coverage Plywood. 3-year price chart.

Hero MotoCorp ACCUMULATE. Performance Highlights. CMP `3,718 Target Price `4,130. 1QFY2018 Result Update Automobile. 3-year price chart

KEI Industries BUY. Performance Update. CMP Target Price `433 `508. 4QFY2018 Result Update Cable. Historical share price chart.

Graphite India BUY. Performance Highlights. CMP Target Price `88 `109. 1QFY2012 Result Update Capital Goods

Mahindra & Mahindra Ltd.

Blue Star Ltd BUY. Performance Update. CMP Target Price `754 `867. 4QFY2018 Result Update Cons. Durable. 3-year price chart.

TV Today Network BUY. Performance Update. CMP Target Price `315 `385. 2QFY2017 Result Update Media. Historical share price chart.

LT Foods BUY. Performance Update. CMP Target Price `92 `128. 3QFY2018 Result Update Media February 12, 2018

Transport Corporation of India

LT Foods BUY. Performance Update. CMP Target Price `76 `128. 4QFY2018 Result Update Media

ACC NEUTRAL. Performance Highlights. CMP `1,261 Target Price - 4QCY2012 Result Update Cement. Quarterly results (Standalone) Investment Period -

Jindal Steel & Power BUY. CMP Target Price `200 `320. 1QFY2019 Result Update Steel & Power. Performance Update

Goodyear India BUY. Performance Highlights. CMP Target Price `487 `582. 4QFY2016 Result Update Tyres. 3-year Daily Price Chart.

Ambuja Cements NEUTRAL. Performance Highlights CMP. `184 Target Price - 2QCY2012 Result Update Cement. Quarterly results (Standalone)

CCL Products BUY. Brewing Steadily. CMP Target Price `300 `360. Initiating Coverage Coffee. January 4, year price chart

SpiceJet BUY. Performance Highlights CMP. `32 Target Price `43. 1QFY2013 Result Update Airlines. Investment Period 12 Months.

Sanofi India ACCUMULATE. Performance Highlights. CMP `4,410 Target Price `4,738. 1QCY2016 Result Update Pharmaceutical. 3-year price chart

Century Plyboards Ltd

Cadila Healthcare NEUTRAL. Performance Highlights CMP. `495 Target Price - 4QFY2017 Result Update Pharmaceutical.

Visaka Industries BUY. Performance Highlights CMP. `119 Target Price `144. 2QFY2016 Result Update Cement Products. Investment Period 12 Months

MRF BUY. Performance Highlights. CMP `40,703 Target Price `47,548. 1QSY2015 Result Update Tyre

TVS Motor Company BUY. Performance Highlights. CMP Target Price `39 `45. 2QFY2013 Result Update Automobile. Quarterly highlights (Standalone)

Quick take. Ashok Leyland Ltd BUY. Scrappage policy to drive faster growth. Target Price. Investment Period 12 Months. 3-year price chart

Ambuja Cements NEUTRAL. Performance Highlights CMP. `155 Target Price - 1QCY2011 Result Update Cement. Investment Period - Key financials (Standalone)

CCL Products BUY. Performance Update. CMP Target Price `278 `360. 3QFY2018 Result Update Coffee. Historical share price chart.

Sanofi India NEUTRAL. Performance Highlights. CMP `4,301 Target Price - 4QCY2016 Result Update Pharmaceutical. Investment Period - 3-year price chart

Sanofi India NEUTRAL. Performance Highlights. CMP `4,007 Target Price - 3QCY2017 Result Update Pharmaceutical. Investment Period 12 months

Quick take. VIP Industries BUY. Travelling smart on the luggage track. CMP Target Price `153 ` year daily price chart

Sanofi India NEUTRAL. Performance Highlights. CMP `4,007 Target Price - 2QCY2017 Result Update Pharmaceutical. 3-year price chart.

Simplex Infrastructures

ICICI Bank BUY. Performance Highlights. CMP Target Price `328 `416. 3QFY2018 Result Update Banking. 3-year price chart. Key financials (Standalone)

Tata Consultancy Services (TCS)

LIC Housing Finance BUY. Performance Highlights. CMP Target Price `532 `630. 3QFY2017 Result Update HFC. 3-Year Daily Price Chart

Federal Bank BUY. Performance Highlights. Target Price. 1QFY2018 Result Update Banking. Stock Info Sector

ICICI Bank BUY. Performance Highlights. CMP Target Price `343 `460. Q3FY2019 Result Update Banking. 3-year price chart. Exhibit 1: Key Financials

Cairn India ACCUMULATE. Performance Highlights. CMP Target Price `338 `382. 2QFY2013 Result Update Oil & Gas. Quarterly highlights (Consolidated)

BGR Energy Systems NEUTRAL. Performance Highlights CMP. `235 Target Price - 3QFY2013 Result Update Capital Goods. Investment Period -

Dr. Reddy s Laboratories

Dewan Housing Finance

Matrimony.com Ltd BUY. Performance Update. Target Price `1,016. 4QFY2018 Result Update Cable. Historical share price chart.

MISHRA DHATU NIGAM Ltd.

ICICI Bank BUY. Performance Highlights. CMP Target Price `307 `411. 1QFY2019 Result Update Banking. 3-year price chart. Key financials (Standalone)

ITD Cementation India

Cadila Healthcare NEUTRAL. Performance Highlights CMP. `390 Target Price - 2QFY2017 Result Update Pharmaceutical. Investment Period -

Quick take. Aditya Birla Nuvo BUY. Deep Value. Valuation Methodology. Exhibit 1: ABNL s Business Structure

Cadila Healthcare NEUTRAL. Performance Highlights CMP. `440 Target Price. 3QFY2017 Result Update Pharmaceutical. Investment Period -

Prakash Industries BUY. Performance Highlights. CMP Target Price `81 `124. 3QFY2011 Result Update Steel

Apollo Micro Systems Ltd

Varroc Engineering Ltd.

HDFC Bank BUY. Performance Highlights. CMP `2,145 Target Price `2,500. Q3FY2019 Result Update Banking. 3-year price chart. Key financials (Standalone)

Dr Reddy s Laboratories

Matrimony.com Ltd BUY. A complete package from matchmaking to wedding. Target Price. Initiating Coverage Internet Software & Services

Lupin BUY. Performance Highlights. CMP `1,493 Target Price `1,809. 2QFY2017 Result Update Pharmaceutical. 3-year price chart

Voltas BUY. Performance Highlights CMP. `327 Target Price `407. 4QFY2016 Result Update Construction & Eng. Quarterly highlights - Consolidated

Alembic BUY. Performance Highlights. Target Price. 1QFY2011 Result Update Pharmaceutical. Investment Period 12 months

Aurobindo Pharma ACCUMULATE. Performance Highlights. `780 Target Price CMP `855. 2QFY2019 Result Update Pharmaceutical. Investment Period 12 months

Apollo Tyres BUY. Performance Highlights. CMP Target Price `71 `82. 4QFY2011Result Update Tyre. Key financials (Consolidated)

HDFC Bank BUY. Performance Highlights. CMP `1,965 Target Price `2,350. Q2FY2019 Result Update Banking. 3-year price chart. Exhibit 1: Key Financials

Cipla REDUCE. Performance Highlights. CMP Target Price `564 `490. 2QFY2017 Result Update Pharmaceutical. Investment Period - 3-Year Daily Price Chart

Newgen Software Technologies Ltd

Maruti Suzuki ACCUMULATE. Performance Highlights. CMP `7,622 Target Price `8,501. 1QFY2018 Result Update Automobile

SUN TV Network NEUTRAL. Performance Highlights CMP. `297 Target Price - 1QFY2013 Result Update Media. Investment Period -

Transcription:

2QFY216 Result Update Capital Goods November 17, 215 Kirloskar Oil Engines Performance Highlights Y/E March (` cr) 2QFY16 2QFY15 % chg. (yoy) 1QFY15 % chg. (qoq) Net Sales 59 628 (6.) 582 1.5 EBITDA 48 64 (24.3) 53 (8.1) EBITDA margin (%) 8.2 1.2 (198) 9. (86) PAT 36 35 1.1 36 (.5) (Standalone) For 2QFY216, Kirloskar Oil Engines (KOEL) reported a disappointing set of numbers. Its top-line for the quarter declined by 6.% yoy to `59cr. The raw material cost declined by 286bp yoy to 62.3% of sales while employee expense increased by 79bp yoy to 8.5% of sales, and other expenses increased by 45bp yoy to 21.% of sales. This resulted in the EBITDA margin contracting by 198bp yoy to 8.2%. Other income increased by 61.1% yoy to `2cr and consequently, the net profit remained flat at `36cr. Outlook to remain subdued in the near term: In the near term, we expect the company to witness some pressure on account of overall slowdown in the Genset industry. In addition, the absence of large engines orders has been impacting the top-line and profitability. KOEL has expanded its capacity in the past and is positioned to successfully cater to improvement in demand once the operating environment changes in the longer run. KOEL also has taken measures to increase its focus on exports which should aid growth. Cash rich position: KOEL is a debt free company with cash and cash equivalents of approximately `835cr. With ample capacity in place, there is no major capex expected in the near future. Consequently depreciation expense is also expected to remain low which will add to the bottom-line. We expect KOEL s cash and cash equivalents to be at ~`982cr in FY217E which is approximately 26% of the current market cap. Outlook and Valuation: We expect KOEL s revenue to recover post FY216, ie to `2,826cr in FY217E. With recovery in the top-line, we expect the EBITDA margin to recover to 1.4% in FY217E. Consequently the profit is expected to grow to `193cr in FY217E. We have scaled down our numbers for FY216E and have accounted for improvement in the top-line for FY217E. At the current market price, the stock trades at 19.7x its FY217E earnings (vs its 3-year median of 21.7x). At the current juncture, we have a Neutral rating on the stock as the infrastructure scenario in the country is expected to remain dampened in the near term. Key financials Y/E March (` cr) FY213 FY214 FY215 FY216E FY217E Net Sales 2,357 2,319 2,57 2,471 2,826 % chg 1.3 (1.6) 8.1 (1.4) 14.3 Adj. Net Profit 212 178 143 132 193 % chg 35.2 (15.9) (19.8) (7.8) 46.1 OPM (%) 13.8 13.1 9.9 8.8 1.4 EPS (`) 14.7 12.3 9.9 9.1 13.3 P/E (x) 17.9 21.2 26.5 28.7 19.7 P/BV (x) 3.3 3. 2.8 2.7 2.5 RoE (%) 19.4 14.7 11. 9.7 13.4 RoCE (%) 19.4 16.4 1.9 8. 12.4 EV/Sales (x) 1.4 1.4 1.2 1.2 1. EV/EBITDA (x) 1.3 1.3 11.6 13.4 9.5, Note: CMP as of November 13, 215 NEUTRAL CMP `262 Target Price - Investment Period - Stock Info Sector Capital Goods Market Cap (` cr) 3,796 Net debt (` cr) (876) Beta.6 52 Week High / Low 261/ 141 Avg. Daily Volume 26,711 Face Value (`) 2 BSE Sensex 25,76 Nifty 7,87 Reuters Code Bloomberg Code KIRO.BO KOEL IN Shareholding Pattern (%) Promoters 72.7 MF / Banks / Indian Fls 6.6 FII / NRIs / OCBs 1.4 Indian Public / Others 1.3 Abs.(%) 3m 1yr 3yr Sensex (7.6) (8.6) 4.7 KOEL (.8) 1.7 39.4 3 Year price chart Milan Desai 22 4 36 Ext: 6846 milan.desai@angelbroking.com Please refer to important disclosures at the end of this report 1 (`) 4 35 3 25 2 15 1 5 Nov-12 Feb-13 May-13 Aug-13 Nov-13 Feb-14 May-14 Aug-14 Nov-14 Feb-15 May-15 Aug-15 Nov-15

Exhibit 1: 2QFY216 performance highlights Y/E March (` cr) 2QFY16 2QFY15 % chg. (yoy) 1QFY15 % chg. (qoq) 1HFY216 1HFY215 % chg Net Sales 59 628 (6.) 582 1.5 1,171 1,267 (7.5) Net raw material 368 49 (1.2) 373 (1.5) 741 825 (1.2) (% of Sales) 62.3 65.2 (286) 64.2 (186) 63.2 65.1 (2.9) Employee Cost 5 48 3.6 48 5.5 98 94 3.8 (% of Sales) 8.5 7.7 79 8.2 32 8.3 7.4 12.2 Other Expenses 124 16 16.4 18 14.5 232 28 11.3 (% of Sales) 21. 16.9 45 18.6 239 19.8 16.5 2.4 Total Expenditure 542 564 (4.) 529 2.4 1,71 1,128 (5.1) Operating Profit 48 64 (24.3) 53 (8.1) 11 139 (27.6) OPM (%) 8.2 1.2 (198) 9. (86) 8.6 11. (238) Interest (86.7) (33.3) (79.2) Depreciation 27 26 3.9 26 2.4 53 5 5.4 Other Income 2 12 61.1 19 2.2 39 26 49.4 PBT 41 5 (17.9) 46 (9.8) 87 115 (24.5) (% of Sales) 7. 8. 7.8 7.4 9.1 Tax 5 15 (63.5) 1 (44.4) 15 32 (53.1) (% of PBT) 13.1 29.4 21.2 17.4 28. Reported PAT 36 35 1.1 36 (.5) 72 83 (13.3) Extraordinary Expense/(Inc.) - - - - - Adjusted PAT 36 35 1.1 36 (.5) 72 83 (13.3) PATM 6.1 5.6 6.2 6.1 6.5 Exhibit 2: Top-line remains subdued (` cr) 7 6 5 4 3 2 1 517 (15.7) 569 21.4 7.4 7.5 5.4 8.2 (2.8) (9.) 643 639 628 612 625 582 59 2QFY14 3QFY14 4QFY14 1QFY15 2QFY15 3QFY15 4QFY15 1QFY16 2QFY16 Revenue (LHS) yoy growth (RHS) 4 2 (%) (6.) (2) Exhibit 3: PowerGen Segment growth (` Cr) 35 3 25 2 15 1 5 183 2QFY14 (27.7) 183 3QFY14 (9.9) 265 4QFY14 9.1 291 1QFY15 27.1 PowerGen (LHS) 264 2QFY15 44.3 255 3QFY15 39.3 289 4QFY15 9.1 276 1QFY16 (5.2) yoy growth (RHS) 265 2QFY16 5. 4. 3. 2. 1..4 - (1.) (2.) (3.) (4.) (%) Top-line growth remains subdued For 2QFY216, the top-line declined by 6.% yoy to `59cr. The decline was on account of a muted performance across all segments and due to absence of large engine orders in FY216 (last portion of the order completed in FY215). As per the Management, the domestic power gen segment saw a decline of 4% in 1HFY216E. Exports performed well, growing by 27% on a yoy basis. November 17, 215 2

Exhibit 4: Segmental Performance (` Cr) 2QFY16 2QFY15 % chg. (yoy) 1HFY16 1HFY15 % chg. (yoy) PowerGen 265 264.5 541 555 (2.4) Agricultural 17 113 (5.8) 26 25.4 Industrial 99 94 5. 19 193 (1.6) Customer Support 83 85 (2.4) 172 177 (2.7) Large Engines 31 67 (54.3) 52 122 (57.4) Total 584 623 1,162 1,252 EBITDA Margin contracts on account of higher other expenses The raw material cost declined by 286bp yoy to 62.3% of sales while employee expense increased by 79bp yoy to 8.5% of sales, and other expenses increased by 45bp yoy to 21.% of sales. This resulted in the EBITDA margin contracting by 198bp yoy to 8.2%. As per the Management, the other expense was higher as there was a one-off expense related to payment of consultancy fees and shifting of manufacturing from Pune plant to Kagal plant. The fixed portion of the fees (~`7- `8cr) was paid up front. Additionally, the CSR expense which was incurred in the last quarter of the previous year has been spread out evenly in the current year. As on 1HFY216, the expense was `3cr against `1-`2 lakhs in the same period last year. Aided by higher other income which grew by 61.1% yoy to `2cr, the net profit grew marginally by 1.1% yoy to `36cr. Exhibit 5: EBITDA margin Exhibit 6: Net profit trend (` cr) 9 8 7 6 5 4 3 2 1 11.6 6 EBITDA (LHS) 13.7 13. 11.8 78 84 75 1.2 64 EBITDA Margin (RHS) 9.5 9. 8.2 8.2 58 51 53 48 16 14 12 1 8 6 4 2 (%) (` cr) 6 5 4 3 2 1 31 45 (44.9) 2QFY14 3QFY14 4QFY14 1QFY15 2QFY15 3QFY15 4QFY15 1QFY16 2QFY16 PAT (LHS).9 (16.1) (1.6) 5 47 35 yoy growth (RHS) 2 15.2 1 1.1 (1) (2) (24.7) (24.1) (3) 34 26 36 36 (46.7) (4) (5) 2QFY14 3QFY14 (%) 4QFY14 1QFY15 2QFY15 3QFY15 4QFY15 1QFY16 2QFY16 November 17, 215 3

Conference Call Highlights Economic revival has been sluggish and has had a direct impact on the PowerGen and Industrial segment. The Agri business was impacted on account of shift in demand towards electrical pump sets as electrification has improved. Spare sales were lower on account of low usage of DG set and lesser industrial activities. The competitive scenario is intense in the sub-125kva segment and everybody is scampering for a share of the pie. The domestic PowerGen segment industry saw a decline of 4% in volume terms. Few players in MHP and HHP have taken price cuts of ~4-5%. KOEL has refrained from cutting its prices. Market share increase in PowerGen by ~4-5% for a competitor is on account of pick up in 4G activity (Reliance Jio). Ex of telecom, KOEL maintained its market share. The Management expects telecom to be in a lull over the next few months but it should pick up when the Airtel order comes up. The company has not participated in a big way in 4G but is hopeful that some of the test orders translate in to larger orders. Exports contribution has increased from 8% in 1HFY215 to 1% in 1HFY216. The company expects to maintain its previous growth rates. Tiller volumes are expected to pick up in the next year on account of subsidy application and link up with four major banks for retail financing. Subsidy approval from various state governments will be an important factor in the near term. The company has sold 6 power tillers in 1HFY216. With timely subsidies, the Management is expecting sales of ~5 tillers per month for FY217E. Investment arguments Near term performance subdued; to improve over the longer run The generator set industry in general is facing headwinds on account of delay in pickup in economic recovery. In the past, the industrial and infrastructure segment witnessed persistent headwinds such as inflationary pressures, slow order inflows, high interest rates and policy paralysis, which has resulted in slower execution and dip in demand for gensets. The PowerGen segment accounts for ~45% of total revenues and is impacted by the above mentioned reasons. Although the recovery has been slower than expected, the expected improvement in the economic scenario would impact KOEL positively as it has the necessary capacity in place to cater to an improving scenario. Debt free and cash rich company KOEL is a debt free company with cash and cash equivalents of approximately `835cr. With ample capacity in place, there is no major capex expected in the near future. Consequently depreciation expense is also expected to remain low which will add to the bottom-line. We expect KOEL s cash and cash equivalents to be at ~`982cr in FY217E which is approximately 26% of the current market cap. November 17, 215 4

This is on the back of measures taken by the company to significantly reduce its debtor days from 45 in FY213 to 17 in FY215. Increasing focus on exports a long term growth driver In order to balance out any slowdown in the domestic economy, the company is focusing on the export market. The company s major export markets are Middle East and Africa along with USA, Europe and South Asia/South East Asia. Middle East accounts for 47% of total exports and Africa accounts for 37%. The company is upping its focus on exports and plans to enter new markets while also increasing its market share in existing markets. The company expects Middle East and Africa to be larger contributors to the international business of the company and is taking steps to increase its presence in USA where it has less of a presence. Financials Slow recovery in top-line On account of overall slowdown in the PowerGen and Industrial segment along with absence of large engine orders, we expect the top-line to regress in FY216E and recover in FY217E to `2,826cr. The margins are expected to remain under pressure for the current year on account of lower sales and on account of some one-time expenses in the current year (Shifting to Kagal plant and Consultancy fees). We expect the EBITDA margin to improve on account of operating leverage and also due to higher-margin large engine orders coming in FY217E. Exhibit 7: Revenue growth to improve going forward Exhibit 8: EBITDA margin to recover 3, 2,5 2, 8.1 2 14.3 1 35 3 13.1 13.8 13.1 9.9 8.8 1.4 16 14 12 1 (` cr) 1,5 1, 5 2326 (4.) 2357 1.3 2,319 (1.6) 2,57 2,471 (1.4) 2,826 (%) (` cr) 25 34 326 34 249 218 295 8 6 4 2 (%) - FY212 FY213 FY214 FY215 FY216E FY217E (1) 2 FY212 FY213 FY214 FY215 FY216E FY217E Revenue (LHS) Revenue growth (RHS) EBITDA (LHS) EBITDA Margin (RHS) The depreciation expense is expected to be flat as the company has undertaken capacity expansion in the past to position itself to best cater to the future uptick in demand. With no significant capex in sight, the flat depreciation is expected to add directly to the bottom-line. The cash position is expected to remain strong and as per our estimates, the cash and cash equivalents are expected to be at `982cr in FY217E. On account of operating leverage, the PAT for FY217E is expected to improve to `193cr. November 17, 215 5

Exhibit 9: Relative valuation (Trailing twelve months) Company Mcap Sales OPM PAT EPS RoIC P/E P/BV EV/EBITDA EV/ Sales (` cr) (` cr) (%) (` cr) (`) (%) (x) (x) (x) (x) KOEL 3,796 2,48 8.5 132 9.1 17.6 28.7 2.6 14.1 1.2 Cummins India 27,886 28,491 2.7 781 28.2 23.2 35.7 8.5 35.3 1. Greaves Cotton 3,41 1,893 9.4 134 5.5 17.7 25.4 4.1 18.7 1.8 Outlook and valuation: We expect KOEL s revenue to recover post FY216E to `2,826cr in FY217E. With recovery in top-line, we expect the EBITDA margin to recover to 1.4% in FY217E. Consequently the profit is expected to grow to `193cr in FY217E. At the moment, the PowerGen and Industrial segments are facing pressure on account of slower-than-expected recovery in the macroeconomic environment. We have scaled down our numbers for FY216E and have accounted for improvement in the top-line for FY217E. At the current market price, the stock trades at 19.7x its FY217E earnings (vs its 3-year median of 21.7x). At the current juncture, we have a Neutral rating on the stock as the infrastructure scenario in the country remains dampened in the near term. Exhibit 1: One-year forward P/E band 45 4 35 3 (`) 25 2 15 1 5 Nov-11 Jan-12 Mar-12 May-12 Jul-12 Sep-12 Nov-12 Jan-13 Mar-13 May-13 Jul-13 Sep-13 Nov-13 Jan-14 Mar-14 May-14 Jul-14 Sep-14 Nov-14 Jan-15 Mar-15 May-15 Jul-15 Sep-15 Nov-15 Price (`) 12x 17x 22x 27x Concerns Continued slowdown in the economy: Any continued slowdown will adversely affect the company s performance. Surplus electricity scenario: Contracting demand supply gap will be an adverse situation for the company to some extent. Fluctuations in Steel price: Any substantial fluctuation in the steel price can lead to margin compression of the company. Increasing imports from China: Low cost Chinese imports will continue to pose a threat to the company. November 17, 215 6

Company background KOEL is the flagship company of the Kirloskar group, one of India s largest engineering conglomerates. It is one of the world s largest generating set manufacturers, specializing in manufacturing of both air-cooled and water-cooled engines (2.5HP to 74HP) and diesel generating sets across a wide range of power output from 5kVA to 3,kVA. It has four manufacturing plants - at Kagal, Pune, Nashik and Rajkot. It has a sizable presence in international markets, with offices in Dubai, South Africa, and Kenya, and representatives in Indonesia and Nigeria. KOEL also has a strong distribution network throughout the Middle East and Africa. It caters to Power Generation, Agriculture and Industrial and machinery sectors. November 17, 215 7

Profit and loss statement Y/E March (` cr) FY213 FY214 FY215 FY216E FY217E Total operating income 2,357 2,319 2,57 2,471 2,826 % chg 1.3 (1.6) 8.1 (1.4) 14.3 Net Raw Materials 1446 1444 1626 1567 1779 % chg 4. (.2) 12.6 (3.6) 13.5 Power and Fuel 23 21 21 2 2 % chg (17.7) (9.).6 (1.4) (2.8) Personnel 173 163 188 22 222 % chg (1.1) (6.3) 15.9 7. 1. Other 39 388 424 464 51 % chg (9.1) (.3) 9.1 9.5 1. Total Expenditure 2,32 2,15 2,259 2,253 2,531 EBITDA 326 34 249 218 295 % chg 7.1 (6.6) (18.3) (12.3) 35.1 (% of Net Sales) 13.8 13.1 9.9 8.8 1.4 Depreciation& Amortisation 93 98 12 15 111 EBIT 233 26 147 113 184 % chg 9.6 (11.7) (28.8) (23.2) 62.9 (% of Net Sales) 9.9 8.9 5.9 4.6 6.5 Interest & other Charges 2 Other Income 4 38 59 71 85 (% of Net Sales) 1.7 1.6 2.4 2.9 3. Recurring PBT 231 26 147 112 183 % chg 17.5 (11.1) (28.8) (23.2) 63. PBT (reported) 271 243 25 183 268 Tax 72 65 62 51 75 (% of PBT) 26.6 26.7 3.3 28. 28. PAT (reported) 199 178 143 132 193 Extraordinary Expense/(Inc.) 13.4.... ADJ. PAT 212 178 143 132 193 % chg 35.2 (15.9) (19.8) (7.8) 46.1 (% of Net Sales) 9. 7.7 5.7 5.3 6.8 Basic EPS (`) 14.7 12.3 9.9 9.1 13.3 Fully Diluted EPS (`) 14.7 12.3 9.9 9.1 13.3 % chg 35.2 (15.9) (19.8) (7.8) 46.1 November 17, 215 8

Balance sheet Y/E Mar. (` cr) FY213 FY214 FY215 FY216E FY217E SOURCES OF FUNDS Equity Share Capital 29 29 29 29 29 Reserves& Surplus 1,125 1,238 1,313 1,357 1,463 Shareholders Funds 1,154 1,267 1,341 1,386 1,492 Total Loans - - - - - Other Long Term Liabilities 3 13 17 17 17 Long Term Provisions 22 25 24 24 24 Deferred Tax (Net) 34 3 29 29 29 Total liabilities 1,24 1,335 1,412 1,457 1,562 APPLICATION OF FUNDS Gross Block 1,133 1,179 1,249 1,338 1,44 Less: Acc. Depreciation 542 636 736 841 952 Net Block 591 543 514 497 488 Capital Work-in-Progress 27 42 21 22 14 Goodwill - - - - - Investments 418 68 876 824 824 Long Term Loans and adv. 66 96 18 18 18 Other Non-current asset 26 29 32 32 32 Current Assets 615 534 381 485 672 Cash 25 52 25 52 159 Loans & Advances 93 12 1 14 119 Inventory 189 167 172 176 224 Debtors 289 177 53 122 139 Other current assets 21 35 31 31 31 Current liabilities 54 516 521 512 576 Net Current Assets 112 18 (14) (27) 96 Misc. Exp. not written off - - - - - Total Assets 1,24 1,335 1,412 1,457 1,562 November 17, 215 9

Cash flow statement Y/E Mar. (` cr) FY213 FY214 FY215 FY216E FY217E Profit before tax 271 243 25 183 268 Depreciation 93 98 12 15 111 Change in Working Capital (81) 122 131 (86) (17) Direct taxes paid (72) (65) (64) (51) (75) Others 6 (6) (35) (71) (85) Cash Flow from Operations 216 338 339 81 22 (Inc.)/Dec. in Fixed Assets (97) (61) (49) (9) (94) (Inc.)/Dec. in Investments 11 (19) (269) 53 - (Incr)/Decr In LT loans & adv. (9) (33) (16) - - Others 28 59 52 71 85 Cash Flow from Investing 31 (224) (282) 33 (9) Issue of Equity () - - - - Inc./(Dec.) in loans (87) - 4 - - Dividend Paid (Incl. Tax) (85) (85) (87) (87) (87) Others (78) (1) (1) - - Cash Flow from Financing (25) (86) (84) (87) (87) Inc./(Dec.) in Cash (3) 28 (27) 27 16 Opening Cash balances 27 25 52 25 52 Closing Cash balances 25 52 25 52 159 November 17, 215 1

Key ratios Y/E Mar. FY213 FY214 FY215 FY216E FY217E Valuation Ratio (x) P/E (on FDEPS) 17.9 21.2 26.5 28.7 19.7 P/CEPS 12.4 13.7 15.5 16. 12.5 P/BV 3.3 3. 2.8 2.7 2.5 EV/Net sales 1.4 1.4 1.2 1.2 1. EV/EBITDA 1.3 1.3 11.6 13.4 9.5 EV / Total Assets 2.8 2.4 2.1 2. 1.8 Per Share Data (`) EPS (Basic) 14.7 12.3 9.9 9.1 13.3 EPS (fully diluted) 14.7 12.3 9.9 9.1 13.3 Cash EPS 21.1 19.1 16.9 16.4 21. DPS 5. 5. 5. 5. 5. Book Value 79.8 87.6 92.8 95.9 13.2 DuPont Analysis EBIT margin 9.9 8.9 5.9 4.6 6.5 Tax retention ratio.7.7.7.7.7 Asset turnover (x) 3.5 3.5 4.7 5. 5.3 ROIC (Post-tax) 25.1 22.5 19.2 16.4 24.8 Cost of Debt (Post Tax) 3.2 - - - - Leverage (x) (.4) (.5) (.7) (.6) (.7) Operating ROE 16.7 - - - - Returns (%) ROCE (Pre-tax) 19.4 16.4 1.9 8. 12.4 Angel ROIC (Pre-tax) 34.2 3.8 27.6 22.8 34.4 ROE 19.4 14.7 11. 9.7 13.4 Turnover ratios (x) Asset TO (Gross Block) 2 2 2 2 2 Inventory / Net sales (days) 25 28 25 26 26 Receivables (days) 45 37 17 18 18 Payables (days) 93 92 84 83 83 WC cycle (ex-cash) (days) 7 4 (15) (18) (9) Solvency ratios (x) Net debt to equity (.4) (.5) (.7) (.6) (.7) Net debt to EBITDA (1.4) (2.2) (3.6) (4.) (3.3) Int. Coverage (EBIT/ Int.) 124.7 686.5 733.5 563.4 917.6 November 17, 215 11

Research Team Tel: 22-393578 E-mail: research@angelbroking.com Website: www.angelbroking.com DISCLAIMER Angel Broking Private Limited (hereinafter referred to as Angel ) is a registered Member of National Stock Exchange of India Limited, Bombay Stock Exchange Limited and Metropolitan Stock Exchange of India Limited. It is also registered as a Depository Participant with CDSL and Portfolio Manager with SEBI. It also has registration with AMFI as a Mutual Fund Distributor. Angel Broking Private Limited is a registered entity with SEBI for Research Analyst in terms of SEBI (Research Analyst) Regulations, 214 vide registration number INH164. Angel or its associates has not been debarred/ suspended by SEBI or any other regulatory authority for accessing /dealing in securities Market. Angel or its associates including its relatives/analyst do not hold any financial interest/beneficial ownership of more than 1% in the company covered by Analyst. Angel or its associates/analyst has not received any compensation / managed or co-managed public offering of securities of the company covered by Analyst during the past twelve months. Angel/analyst has not served as an officer, director or employee of company covered by Analyst and has not been engaged in market making activity of the company covered by Analyst. This document is solely for the personal information of the recipient, and must not be singularly used as the basis of any investment decision. Nothing in this document should be construed as investment or financial advice. Each recipient of this document should make such investigations as they deem necessary to arrive at an independent evaluation of an investment in the securities of the companies referred to in this document (including the merits and risks involved), and should consult their own advisors to determine the merits and risks of such an investment. Reports based on technical and derivative analysis center on studying charts of a stock's price movement, outstanding positions and trading volume, as opposed to focusing on a company's fundamentals and, as such, may not match with a report on a company's fundamentals. The information in this document has been printed on the basis of publicly available information, internal data and other reliable sources believed to be true, but we do not represent that it is accurate or complete and it should not be relied on as such, as this document is for general guidance only. Angel Broking Pvt. Limited or any of its affiliates/ group companies shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. Angel Broking Pvt. Limited has not independently verified all the information contained within this document. Accordingly, we cannot testify, nor make any representation or warranty, express or implied, to the accuracy, contents or data contained within this document. While Angel Broking Pvt. Limited endeavors to update on a reasonable basis the information discussed in this material, there may be regulatory, compliance, or other reasons that prevent us from doing so. This document is being supplied to you solely for your information, and its contents, information or data may not be reproduced, redistributed or passed on, directly or indirectly. Neither Angel Broking Pvt. Limited, nor its directors, employees or affiliates shall be liable for any loss or damage that may arise from or in connection with the use of this information. Note: Please refer to the important Stock Holding Disclosure' report on the Angel website (Research Section). Also, please refer to the latest update on respective stocks for the disclosure status in respect of those stocks. Angel Broking Pvt. Limited and its affiliates may have investment positions in the stocks recommended in this report. Disclosure of Interest Statement Kirloskar Oil Engines 1. Analyst ownership of the stock No 2. Angel and its Group companies ownership of the stock No 3. Angel and its Group companies' Directors ownership of the stock No 4. Broking relationship with company covered No Note: We have not considered any Exposure below ` 1 lakh for Angel, its Group companies and Directors Ratings (Based on expected returns Buy (> 15%) Accumulate (5% to 15%) Neutral (-5 to 5%) over 12 months investment period): Reduce (-5% to -15%) Sell (< -15) November 17, 215 12